<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">36455453</PMID><DateCompleted><Year>2022</Year><Month>12</Month><Day>20</Day></DateCompleted><DateRevised><Year>2023</Year><Month>02</Month><Day>09</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1872-8952</ISSN><JournalIssue CitedMedium="Internet"><Volume>145</Volume><PubDate><Year>2023</Year><Month>Jan</Month></PubDate></JournalIssue><Title>Clinical neurophysiology : official journal of the International Federation of Clinical Neurophysiology</Title><ISOAbbreviation>Clin Neurophysiol</ISOAbbreviation></Journal><ArticleTitle>Co-ultramicronized palmitoylethanolamide/luteolin normalizes GABA<sub>B</sub>-ergic activity and cortical plasticity in long COVID-19 syndrome.</ArticleTitle><Pagination><StartPage>81</StartPage><EndPage>88</EndPage><MedlinePgn>81-88</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.clinph.2022.10.017</ELocationID><ELocationID EIdType="pii" ValidYN="Y">S1388-2457(22)00938-5</ELocationID><Abstract><AbstractText Label="OBJECTIVE">Transcranial magnetic stimulation (TMS) studies showed that patients with cognitive dysfunction and fatigue after COVID-19 exhibit impaired cortical GABA<sub>B-</sub>ergic activity, as revealed by reduced long-interval intracortical inhibition (LICI). Aim of this study was to test the effects of co-ultramicronized palmitoylethanolamide/luteolin (PEA-LUT), an endocannabinoid-like mediator able to enhance GABA-ergic transmission and to reduce neuroinflammation, on LICI.</AbstractText><AbstractText Label="METHODS">Thirty-nine patients (26 females, mean age 49.9&#xa0;&#xb1;&#xa0;11.4&#xa0;years, mean time from infection 296.7&#xa0;&#xb1;&#xa0;112.3&#xa0;days) suffering from persistent cognitive difficulties and fatigue after mild COVID-19 were randomly assigned to receive either PEA-LUT 700&#xa0;mg&#xa0;+&#xa0;70&#xa0;mg or PLACEBO, administered orally bid for eight weeks. The day before (PRE) and at the end of the treatment (POST), they underwent TMS protocols to assess LICI. We further evaluate short-latency afferent inhibition (SAI) and long-term potentiation (LTP)-like cortical plasticity.</AbstractText><AbstractText Label="RESULTS">Patients treated with PEA-LUT but not with PLACEBO showed a significant increase of LICI and LTP-like cortical plasticity. SAI remained unaffected.</AbstractText><AbstractText Label="CONCLUSIONS">Eight weeks of treatment with PEA-LUT restore GABA<sub>B</sub> activity and cortical plasticity in long Covid patients.</AbstractText><AbstractText Label="SIGNIFICANCE">This study confirms altered physiology of the motor cortex in long COVID-19 syndrome and indicates PEA-LUT as a candidate for the treatment of this post-viral condition.</AbstractText><CopyrightInformation>Copyright &#xa9; 2022 International Federation of Clinical Neurophysiology. Published by Elsevier B.V. All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Versace</LastName><ForeName>Viviana</ForeName><Initials>V</Initials><AffiliationInfo><Affiliation>Department of Neurorehabilitation, Hospital of Vipiteno (SABES-ASDAA), Vipiteno-Sterzing, Lehrkrankenhaus der Paracelsus Medizinischen Privatuniversit&#xe4;t, Italy. Electronic address: viviana.versace@sabes.it.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ortelli</LastName><ForeName>Paola</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Department of Neurorehabilitation, Hospital of Vipiteno (SABES-ASDAA), Vipiteno-Sterzing, Lehrkrankenhaus der Paracelsus Medizinischen Privatuniversit&#xe4;t, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Dezi</LastName><ForeName>Sabrina</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Neurorehabilitation, Hospital of Vipiteno (SABES-ASDAA), Vipiteno-Sterzing, Lehrkrankenhaus der Paracelsus Medizinischen Privatuniversit&#xe4;t, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ferrazzoli</LastName><ForeName>Davide</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Department of Neurorehabilitation, Hospital of Vipiteno (SABES-ASDAA), Vipiteno-Sterzing, Lehrkrankenhaus der Paracelsus Medizinischen Privatuniversit&#xe4;t, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Alibardi</LastName><ForeName>Alessia</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Neurorehabilitation, Hospital of Vipiteno (SABES-ASDAA), Vipiteno-Sterzing, Lehrkrankenhaus der Paracelsus Medizinischen Privatuniversit&#xe4;t, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bonini</LastName><ForeName>Ilenia</ForeName><Initials>I</Initials><AffiliationInfo><Affiliation>Department of Neurorehabilitation, Hospital of Vipiteno (SABES-ASDAA), Vipiteno-Sterzing, Lehrkrankenhaus der Paracelsus Medizinischen Privatuniversit&#xe4;t, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Engl</LastName><ForeName>Michael</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Hospital of Vipiteno (SABES-ASDAA), Vipiteno-Sterzing, Lehrkrankenhaus der Paracelsus Medizinischen Privatuniversit&#xe4;t, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Maestri</LastName><ForeName>Roberto</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Department of Biomedical Engineering, Scientific Institute of Montescano - IRCCS, Istituti Clinici Scientifici Maugeri, Pavia, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Assogna</LastName><ForeName>Martina</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Experimental Neuropsychophysiology Lab, Santa Lucia Foundation IRCCS, Rome, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ajello</LastName><ForeName>Valentina</ForeName><Initials>V</Initials><AffiliationInfo><Affiliation>Department of Cardiac Anesthesia, Tor Vergata University Hospital, Rome, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Pucks-Faes</LastName><ForeName>Elke</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Department of Neurology, Hochzirl Hospital, Zirl, Austria.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Saltuari</LastName><ForeName>Leopold</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Department of Neurorehabilitation, Hospital of Vipiteno (SABES-ASDAA), Vipiteno-Sterzing, Lehrkrankenhaus der Paracelsus Medizinischen Privatuniversit&#xe4;t, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sebastianelli</LastName><ForeName>Luca</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Department of Neurorehabilitation, Hospital of Vipiteno (SABES-ASDAA), Vipiteno-Sterzing, Lehrkrankenhaus der Paracelsus Medizinischen Privatuniversit&#xe4;t, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kofler</LastName><ForeName>Markus</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Neurology, Hochzirl Hospital, Zirl, Austria.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Koch</LastName><ForeName>Giacomo</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Experimental Neuropsychophysiology Lab, Santa Lucia Foundation IRCCS, Rome, Italy; Department of Neuroscience and Rehabilitation, University of Ferrara, Ferrara, Italy.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016449">Randomized Controlled Trial</PublicationType><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2022</Year><Month>11</Month><Day>11</Day></ArticleDate></Article><MedlineJournalInfo><Country>Netherlands</Country><MedlineTA>Clin Neurophysiol</MedlineTA><NlmUniqueID>100883319</NlmUniqueID><ISSNLinking>1388-2457</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>6R8T1UDM3V</RegistryNumber><NameOfSubstance UI="C005958">palmidrol</NameOfSubstance></Chemical><Chemical><RegistryNumber>KUX1ZNC9J2</RegistryNumber><NameOfSubstance UI="D047311">Luteolin</NameOfSubstance></Chemical><Chemical><RegistryNumber>56-12-2</RegistryNumber><NameOfSubstance UI="D005680">gamma-Aminobutyric Acid</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D047311" MajorTopicYN="Y">Luteolin</DescriptorName><QualifierName UI="Q000494" MajorTopicYN="N">pharmacology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D009433" MajorTopicYN="N">Neural Inhibition</DescriptorName><QualifierName UI="Q000502" MajorTopicYN="N">physiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000094024" MajorTopicYN="N">Post-Acute COVID-19 Syndrome</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086382" MajorTopicYN="Y">COVID-19</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D050781" MajorTopicYN="N">Transcranial Magnetic Stimulation</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005680" MajorTopicYN="N">gamma-Aminobutyric Acid</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005221" MajorTopicYN="N">Fatigue</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D019054" MajorTopicYN="N">Evoked Potentials, Motor</DescriptorName><QualifierName UI="Q000502" MajorTopicYN="N">physiology</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">LTP-like cortical plasticity</Keyword><Keyword MajorTopicYN="N">Long Covid</Keyword><Keyword MajorTopicYN="N">Long-interval intracortical inhibition</Keyword><Keyword MajorTopicYN="N">Palmitoylethanolamide</Keyword><Keyword MajorTopicYN="N">Transcranial magnetic stimulation</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2022</Year><Month>7</Month><Day>22</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2022</Year><Month>9</Month><Day>26</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2022</Year><Month>10</Month><Day>31</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2022</Year><Month>12</Month><Day>2</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2022</Year><Month>12</Month><Day>21</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2022</Year><Month>12</Month><Day>1</Day><Hour>18</Hour><Minute>21</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2022</Year><Month>11</Month><Day>11</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">36455453</ArticleId><ArticleId IdType="pmc">PMC9650483</ArticleId><ArticleId IdType="doi">10.1016/j.clinph.2022.10.017</ArticleId><ArticleId IdType="pii">S1388-2457(22)00938-5</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>al-Ghoul W.M., Li Volsi G., Weinberg R.J., Rustioni A. Glutamate immunocytochemistry in the dorsal horn after injury or stimulation of the sciatic nerve of rats. Brain Res Bull. 1993;30(3&#x2013;4):453&#x2013;459.</Citation><ArticleIdList><ArticleId IdType="pubmed">8096161</ArticleId></ArticleIdList></Reference><Reference><Citation>Albanese M., Marrone G., Paolino A., Di Lauro M., Di Daniele F., Chiaramonte C., et al. Effects of Ultramicronized Palmitoylethanolamide (um-PEA) in COVID-19 Early Stages: A Case-Control Study. Pharmaceuticals (Basel) 2022;15(2)</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8878249</ArticleId><ArticleId IdType="pubmed">35215365</ArticleId></ArticleIdList></Reference><Reference><Citation>Andresen S.R., Bing J., Hansen R.M., Biering-S&#xf8;rensen F., Johannesen I.L., Hagen E.M., et al. Ultramicronized palmitoylethanolamide in spinal cord injury neuropathic pain: a randomized, double-blind, placebo-controlled trial. Pain. 2016;157(9):2097&#x2013;2103.</Citation><ArticleIdList><ArticleId IdType="pubmed">27227691</ArticleId></ArticleIdList></Reference><Reference><Citation>Apple A.C., Oddi A., Peluso M.J., Asken B.M., Henrich T.J., Kelly J.D., et al. Risk factors and abnormal cerebrospinal fluid associate with cognitive symptoms after mild COVID-19. Ann Clin Transl Neurol. 2022;9(2):221&#x2013;226.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8862406</ArticleId><ArticleId IdType="pubmed">35043593</ArticleId></ArticleIdList></Reference><Reference><Citation>Appollonio I., Leone M., Isella V., Piamarta F., Consoli T., Villa M.L., et al. The Frontal Assessment Battery (FAB): normative values in an Italian population sample. Neurol Sci. 2005;26(2):108&#x2013;116.</Citation><ArticleIdList><ArticleId IdType="pubmed">15995827</ArticleId></ArticleIdList></Reference><Reference><Citation>Assogna M., Casula E.P., Borghi I., Bonn&#xec; S., Sam&#xe0; D., Motta C., et al. Effects of Palmitoylethanolamide Combined with Luteoline on Frontal Lobe Functions, High Frequency Oscillations, and GABAergic Transmission in Patients with Frontotemporal Dementia. J Alzheimers Dis. 2020;76(4):1297&#x2013;1308.</Citation><ArticleIdList><ArticleId IdType="pubmed">32623398</ArticleId></ArticleIdList></Reference><Reference><Citation>Assogna M., Di Lorenzo F., Martorana A., Koch G. Synaptic Effects of Palmitoylethanolamide in Neurodegenerative Disorders. Biomolecules. 2022;12(8)</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9405819</ArticleId><ArticleId IdType="pubmed">36009055</ArticleId></ArticleIdList></Reference><Reference><Citation>Basavarajappa B.S., Nagre N.N., Xie S., Subbanna S. Elevation of endogenous anandamide impairs LTP, learning, and memory through CB1 receptor signaling in mice. Hippocampus. 2014;24(7):808&#x2013;818.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4077345</ArticleId><ArticleId IdType="pubmed">24648181</ArticleId></ArticleIdList></Reference><Reference><Citation>Beggiato S., Tomasini M.C., Ferraro L. Palmitoylethanolamide (PEA) as a Potential Therapeutic Agent in Alzheimer's Disease. Front Pharmacol. 2019;10:821.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6667638</ArticleId><ArticleId IdType="pubmed">31396087</ArticleId></ArticleIdList></Reference><Reference><Citation>Benussi A., Grassi M., Palluzzi F., Koch G., Di Lazzaro V., Nardone R., et al. Classification Accuracy of Transcranial Magnetic Stimulation for the Diagnosis of Neurodegenerative Dementias. Ann Neurol. 2020;87(3):394&#x2013;404.</Citation><ArticleIdList><ArticleId IdType="pubmed">31925823</ArticleId></ArticleIdList></Reference><Reference><Citation>Bikmullina R., Kici&#x107; D., Carlson S., Nikulin V.V. Electrophysiological correlates of short-latency afferent inhibition: a combined EEG and TMS study. Exp Brain Res. 2009;194(4):517&#x2013;526.</Citation><ArticleIdList><ArticleId IdType="pubmed">19241068</ArticleId></ArticleIdList></Reference><Reference><Citation>Boccella S., Marabese I., Iannotta M., Belardo C., Neugebauer V., Mazzitelli M., et al. Metabotropic Glutamate Receptor 5 and 8 Modulate the Ameliorative Effect of Ultramicronized Palmitoylethanolamide on Cognitive Decline Associated with Neuropathic Pain. Int J Mol Sci. 2019;20(7)</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6480075</ArticleId><ArticleId IdType="pubmed">30970677</ArticleId></ArticleIdList></Reference><Reference><Citation>Caltagirone C., Cisari C., Schievano C., Di Paola R., Cordaro M., Bruschetta G., et al. Co-ultramicronized Palmitoylethanolamide/Luteolin in the Treatment of Cerebral Ischemia: from Rodent to Man. Transl Stroke Res. 2016;7(1):54&#x2013;69.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4720704</ArticleId><ArticleId IdType="pubmed">26706245</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen R., Wang K., Yu J., Howard D., French L., Chen Z., et al. The Spatial and Cell-Type Distribution of SARS-CoV-2 Receptor ACE2 in the Human and Mouse Brains. Front Neurol. 2020;11</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7855591</ArticleId><ArticleId IdType="pubmed">33551947</ArticleId></ArticleIdList></Reference><Reference><Citation>Cordaro M., Cuzzocrea S., Crupi R. An Update of Palmitoylethanolamide and Luteolin Effects in Preclinical and Clinical Studies of Neuroinflammatory Events. Antioxidants (Basel) 2020;9(3)</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7139331</ArticleId><ArticleId IdType="pubmed">32150935</ArticleId></ArticleIdList></Reference><Reference><Citation>Daskalakis Z.J., Farzan F., Barr M.S., Maller J.J., Chen R., Fitzgerald P.B. Long-interval cortical inhibition from the dorsolateral prefrontal cortex: a TMS-EEG study. Neuropsychopharmacology. 2008;33(12):2860&#x2013;2869.</Citation><ArticleIdList><ArticleId IdType="pubmed">18322469</ArticleId></ArticleIdList></Reference><Reference><Citation>Di Lazzaro V., Oliviero A., Tonali P.A., Marra C., Daniele A., Profice P., et al. Noninvasive in vivo assessment of cholinergic cortical circuits in AD using transcranial magnetic stimulation. Neurology. 2002;59(3):392&#x2013;397.</Citation><ArticleIdList><ArticleId IdType="pubmed">12177373</ArticleId></ArticleIdList></Reference><Reference><Citation>Di Lazzaro V., Pilato F., Dileone M., Profice P., Ranieri F., Ricci V., et al. Segregating two inhibitory circuits in human motor cortex at the level of GABAA receptor subtypes: A TMS study. Clin Neurophysiol. 2007;118(10):2207&#x2013;2214.</Citation><ArticleIdList><ArticleId IdType="pubmed">17709293</ArticleId></ArticleIdList></Reference><Reference><Citation>Di Lorenzo F., Martorana A., Ponzo V., Bonn&#xec; S., D'Angelo E., Caltagirone C., et al. Cerebellar theta burst stimulation modulates short latency afferent inhibition in Alzheimer's disease patients. Front Aging Neurosci. 2013;5:2.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3575596</ArticleId><ArticleId IdType="pubmed">23423358</ArticleId></ArticleIdList></Reference><Reference><Citation>Di Stadio A., D'Ascanio L., Vaira L.A., Cantone E., De Luca P., Cingolani C., et al. Ultramicronized Palmitoylethanolamide and Luteolin Supplement Combined with Olfactory Training to Treat Post-COVID-19 Olfactory Impairment: A Multi-Center Double-Blinded Randomized Placebo-Controlled Clinical Trial. Curr Neuropharmacol. 2022;20(10):2001&#x2013;2012.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9886808</ArticleId><ArticleId IdType="pubmed">35450527</ArticleId></ArticleIdList></Reference><Reference><Citation>Douaud G., Lee S., Alfaro-Almagro F., Arthofer C., Wang C., McCarthy P., et al. SARS-CoV-2 is associated with changes in brain structure in UK Biobank. Nature. 2022;604(7907):697&#x2013;707.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9046077</ArticleId><ArticleId IdType="pubmed">35255491</ArticleId></ArticleIdList></Reference><Reference><Citation>Farzan F., Barr M.S., Levinson A.J., Chen R., Wong W., Fitzgerald P.B., et al. Reliability of long-interval cortical inhibition in healthy human subjects: a TMS-EEG study. J Neurophysiol. 2010;104(3):1339&#x2013;1346.</Citation><ArticleIdList><ArticleId IdType="pubmed">20573972</ArticleId></ArticleIdList></Reference><Reference><Citation>Fatih P., Kucuker M.U., Vande Voort J.L., Doruk Camsari D., Farzan F., Croarkin P.E. A Systematic Review of Long-Interval Intracortical Inhibition as a Biomarker in Neuropsychiatric Disorders. Front Psychiatry. 2021;12</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8206493</ArticleId><ArticleId IdType="pubmed">34149483</ArticleId></ArticleIdList></Reference><Reference><Citation>Galic M.A., Riazi K., Pittman Q.J. Cytokines and brain excitability. Front Neuroendocrinol. 2012;33(1):116&#x2013;125.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3547977</ArticleId><ArticleId IdType="pubmed">22214786</ArticleId></ArticleIdList></Reference><Reference><Citation>Guedj E., Campion J.Y., Dudouet P., Kaphan E., Bregeon F., Tissot-Dupont H., et al. (18)F-FDG brain PET hypometabolism in patients with long COVID. Eur J Nucl Med Mol Imaging. 2021;48(9):2823&#x2013;2833.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7837643</ArticleId><ArticleId IdType="pubmed">33501506</ArticleId></ArticleIdList></Reference><Reference><Citation>Guida F., Luongo L., Marmo F., Romano R., Iannotta M., Napolitano F., et al. Palmitoylethanolamide reduces pain-related behaviors and restores glutamatergic synapses homeostasis in the medial prefrontal cortex of neuropathic mice. Mol Brain. 2015;8:47.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4532244</ArticleId><ArticleId IdType="pubmed">26260027</ArticleId></ArticleIdList></Reference><Reference><Citation>Gustine J.N., Jones D. Immunopathology of Hyperinflammation in COVID-19. Am J Pathol. 2021;191(1):4&#x2013;17.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7484812</ArticleId><ArticleId IdType="pubmed">32919977</ArticleId></ArticleIdList></Reference><Reference><Citation>Huang C., Huang L., Wang Y., Li X., Ren L., Gu X., et al. 6-month consequences of COVID-19 in patients discharged from hospital: a cohort study. Lancet. 2021;397(10270):220&#x2013;232.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7833295</ArticleId><ArticleId IdType="pubmed">33428867</ArticleId></ArticleIdList></Reference><Reference><Citation>Huang Y.Z., Edwards M.J., Rounis E., Bhatia K.P., Rothwell J.C. Theta burst stimulation of the human motor cortex. Neuron. 2005;45(2):201&#x2013;206.</Citation><ArticleIdList><ArticleId IdType="pubmed">15664172</ArticleId></ArticleIdList></Reference><Reference><Citation>Kano M. Control of synaptic function by endocannabinoid-mediated retrograde signaling. Proc Jpn Acad Ser B Phys Biol Sci. 2014;90(7):235&#x2013;250.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4237895</ArticleId><ArticleId IdType="pubmed">25169670</ArticleId></ArticleIdList></Reference><Reference><Citation>Kramar C., Loureiro M., Renard J., Laviolette S.R. Palmitoylethanolamide Modulates GPR55 Receptor Signaling in the Ventral Hippocampus to Regulate Mesolimbic Dopamine Activity, Social Interaction, and Memory Processing. Cannabis Cannabinoid Res. 2017;2(1):8&#x2013;20.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5531370</ArticleId><ArticleId IdType="pubmed">28861501</ArticleId></ArticleIdList></Reference><Reference><Citation>Krupp L.B., LaRocca N.G., Muir-Nash J., Steinberg A.D. The fatigue severity scale. Application to patients with multiple sclerosis and systemic lupus erythematosus. Arch Neurol. 1989;46(10):1121&#x2013;1123.</Citation><ArticleIdList><ArticleId IdType="pubmed">2803071</ArticleId></ArticleIdList></Reference><Reference><Citation>Liepert J., Mingers D., Heesen C., B&#xe4;umer T., Weiller C. Motor cortex excitability and fatigue in multiple sclerosis: a transcranial magnetic stimulation study. Mult Scler. 2005;11(3):316&#x2013;321.</Citation><ArticleIdList><ArticleId IdType="pubmed">15957514</ArticleId></ArticleIdList></Reference><Reference><Citation>Lunardelli M.L., Crupi R., Siracusa R., Cocuzza G., Cordaro M., Martini E., et al. Co-ultraPEALut: Role in Preclinical and Clinical Delirium Manifestations. CNS Neurol Disord: Drug Targets. 2019;18(7):530&#x2013;554.</Citation><ArticleIdList><ArticleId IdType="pubmed">31244434</ArticleId></ArticleIdList></Reference><Reference><Citation>Lutz B., Marsicano G., Maldonado R., Hillard C.J. The endocannabinoid system in guarding against fear, anxiety and stress. Nat Rev Neurosci. 2015;16(12):705&#x2013;718.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5871913</ArticleId><ArticleId IdType="pubmed">26585799</ArticleId></ArticleIdList></Reference><Reference><Citation>Maccarrone M. Metabolism of the Endocannabinoid Anandamide: Open Questions after 25 Years. Front Mol Neurosci. 2017;10:166.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5447297</ArticleId><ArticleId IdType="pubmed">28611591</ArticleId></ArticleIdList></Reference><Reference><Citation>Mukerjee S., Gao H., Xu J., Sato R., Zsombok A., Lazartigues E. ACE2 and ADAM17 Interaction Regulates the Activity of Presympathetic Neurons. Hypertension. 2019;74(5):1181&#x2013;1191.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6785402</ArticleId><ArticleId IdType="pubmed">31564162</ArticleId></ArticleIdList></Reference><Reference><Citation>Musella A., Fresegna D., Rizzo F.R., Gentile A., Bullitta S., De Vito F., et al. A novel crosstalk within the endocannabinoid system controls GABA transmission in the striatum. Sci Rep. 2017;7(1):7363.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5544685</ArticleId><ArticleId IdType="pubmed">28779174</ArticleId></ArticleIdList></Reference><Reference><Citation>Najjar S., Najjar A., Chong D.J., Pramanik B.K., Kirsch C., Kuzniecky R.I., et al. Central nervous system complications associated with SARS-CoV-2 infection: integrative concepts of pathophysiology and case reports. J Neuroinflammation. 2020;17(1):231.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7406702</ArticleId><ArticleId IdType="pubmed">32758257</ArticleId></ArticleIdList></Reference><Reference><Citation>Nalbandian A., Sehgal K., Gupta A., Madhavan M.V., McGroder C., Stevens J.S., et al. Post-acute COVID-19 syndrome. Nat Med. 2021;27(4):601&#x2013;615.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8893149</ArticleId><ArticleId IdType="pubmed">33753937</ArticleId></ArticleIdList></Reference><Reference><Citation>Nardone R., Bratti A., Tezzon F. Motor cortex inhibitory circuits in dementia with Lewy bodies and in Alzheimer's disease. J Neural Transm (Vienna) 2006;113(11):1679&#x2013;1684.</Citation><ArticleIdList><ArticleId IdType="pubmed">17024328</ArticleId></ArticleIdList></Reference><Reference><Citation>Noda Y., Zomorrodi R., Backhouse F., Cash R.F.H., Barr M.S., Rajji T.K., et al. Reduced Prefrontal Short-Latency Afferent Inhibition in Older Adults and Its Relation to Executive Function: A TMS-EEG Study. Front Aging Neurosci. 2017;9:119.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5411436</ArticleId><ArticleId IdType="pubmed">28512429</ArticleId></ArticleIdList></Reference><Reference><Citation>Oliviero A., Corbo G., Tonali P.A., Pilato F., Saturno E., Dileone M., et al. Functional involvement of central nervous system in acute exacerbation of chronic obstructive pulmonary disease A preliminary transcranial magnetic stimulation study. J Neurol. 2002;249(9):1232&#x2013;1236.</Citation><ArticleIdList><ArticleId IdType="pubmed">12242545</ArticleId></ArticleIdList></Reference><Reference><Citation>Onesti E., Frasca V., Ceccanti M., Tartaglia G., Gori M.C., Cambieri C., et al. Short-Term Ultramicronized Palmitoylethanolamide Therapy in Patients with Myasthenia Gravis: a Pilot Study to Possible Future Implications of Treatment. CNS Neurol Disord: Drug Targets. 2019;18(3):232&#x2013;238.</Citation><ArticleIdList><ArticleId IdType="pubmed">30706796</ArticleId></ArticleIdList></Reference><Reference><Citation>Ortelli P., Ferrazzoli D., Sebastianelli L., Maestri R., Dezi S., Spampinato D., et al. Altered motor cortex physiology and dysexecutive syndrome in patients with fatigue and cognitive difficulties after mild COVID-19. Eur J Neurol. 2022;29(6):1652&#x2013;1662.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9111319</ArticleId><ArticleId IdType="pubmed">35138693</ArticleId></ArticleIdList></Reference><Reference><Citation>Palma E., Reyes-Ruiz J.M., Lopergolo D., Roseti C., Bertollini C., Ruffolo G., et al. Acetylcholine receptors from human muscle as pharmacological targets for ALS therapy. Proc Natl Acad Sci U S A. 2016;113(11):3060&#x2013;3065.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4801305</ArticleId><ArticleId IdType="pubmed">26929355</ArticleId></ArticleIdList></Reference><Reference><Citation>Petrosino S., Di Marzo V. The pharmacology of palmitoylethanolamide and first data on the therapeutic efficacy of some of its new formulations. Br J Pharmacol. 2017;174(11):1349&#x2013;1365.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5429331</ArticleId><ArticleId IdType="pubmed">27539936</ArticleId></ArticleIdList></Reference><Reference><Citation>Phetsouphanh C., Darley D.R., Wilson D.B., Howe A., Munier C.M.L., Patel S.K., et al. Immunological dysfunction persists for 8 months following initial mild-to-moderate SARS-CoV-2 infection. Nat Immunol. 2022;23(2):210&#x2013;216.</Citation><ArticleIdList><ArticleId IdType="pubmed">35027728</ArticleId></ArticleIdList></Reference><Reference><Citation>Porges E.C., Woods A.J., Edden R.A., Puts N.A., Harris A.D., Chen H., et al. Frontal Gamma-Aminobutyric Acid Concentrations Are Associated With Cognitive Performance in Older Adults. Biol Psychiatry Cogn Neurosci Neuroimaging. 2017;2(1):38&#x2013;44.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5312683</ArticleId><ArticleId IdType="pubmed">28217759</ArticleId></ArticleIdList></Reference><Reference><Citation>Premoli I., Rivolta D., Espenhahn S., Castellanos N., Belardinelli P., Ziemann U., et al. Characterization of GABAB-receptor mediated neurotransmission in the human cortex by paired-pulse TMS-EEG. Neuroimage. 2014;103:152&#x2013;162.</Citation><ArticleIdList><ArticleId IdType="pubmed">25245814</ArticleId></ArticleIdList></Reference><Reference><Citation>Proal A.D., VanElzakker M.B. Long COVID or Post-acute Sequelae of COVID-19 (PASC): An Overview of Biological Factors That May Contribute to Persistent Symptoms. Front Microbiol. 2021;12</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8260991</ArticleId><ArticleId IdType="pubmed">34248921</ArticleId></ArticleIdList></Reference><Reference><Citation>Ramani A., M&#xfc;ller L., Ostermann P.N., Gabriel E., Abida-Islam P., M&#xfc;ller-Schiffmann A., et al. SARS-CoV-2 targets neurons of 3D human brain organoids. EMBO J. 2020;39(20):e106230.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7560208</ArticleId><ArticleId IdType="pubmed">32876341</ArticleId></ArticleIdList></Reference><Reference><Citation>Renaud-Charest O., Lui L.M.W., Eskander S., Ceban F., Ho R., Di Vincenzo J.D., et al. Onset and frequency of depression in post-COVID-19 syndrome: A systematic review. J Psychiatr Res. 2021;144:129&#x2013;137.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8482840</ArticleId><ArticleId IdType="pubmed">34619491</ArticleId></ArticleIdList></Reference><Reference><Citation>Ridding M.C., Inzelberg R., Rothwell J.C. Changes in excitability of motor cortical circuitry in patients with Parkinson's disease. Ann Neurol. 1995;37(2):181&#x2013;188.</Citation><ArticleIdList><ArticleId IdType="pubmed">7847860</ArticleId></ArticleIdList></Reference><Reference><Citation>Rossini P.M., Barker A.T., Berardelli A., Caramia M.D., Caruso G., Cracco R.Q., et al. Non-invasive electrical and magnetic stimulation of the brain, spinal cord and roots: basic principles and procedures for routine clinical application. Report of an IFCN committee. Electroencephalogr Clin Neurophysiol. 1994;91(2):79&#x2013;92.</Citation><ArticleIdList><ArticleId IdType="pubmed">7519144</ArticleId></ArticleIdList></Reference><Reference><Citation>Rossini P.M., Burke D., Chen R., Cohen L.G., Daskalakis Z., Di Iorio R., et al. Non-invasive electrical and magnetic stimulation of the brain, spinal cord, roots and peripheral nerves: Basic principles and procedures for routine clinical and research application. An updated report from an I.F.C.N. Committee. Clin Neurophysiol. 2015;126(6):1071&#x2013;1107.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6350257</ArticleId><ArticleId IdType="pubmed">25797650</ArticleId></ArticleIdList></Reference><Reference><Citation>Santangelo G., Siciliano M., Pedone R., Vitale C., Falco F., Bisogno R., et al. Normative data for the Montreal Cognitive Assessment in an Italian population sample. Neurol Sci. 2015;36(4):585&#x2013;591.</Citation><ArticleIdList><ArticleId IdType="pubmed">25380622</ArticleId></ArticleIdList></Reference><Reference><Citation>Sohal V.S., Zhang F., Yizhar O., Deisseroth K. Parvalbumin neurons and gamma rhythms enhance cortical circuit performance. Nature. 2009;459(7247):698&#x2013;702.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3969859</ArticleId><ArticleId IdType="pubmed">19396159</ArticleId></ArticleIdList></Reference><Reference><Citation>Sollini M., Morbelli S., Ciccarelli M., Cecconi M., Aghemo A., Morelli P., et al. Long COVID hallmarks on [18F]FDG-PET/CT: a case-control study. Eur J Nucl Med Mol Imaging. 2021;48(10):3187&#x2013;3197.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7937050</ArticleId><ArticleId IdType="pubmed">33677642</ArticleId></ArticleIdList></Reference><Reference><Citation>Song E, Zhang C, Israelow B, Lu-Culligan A, Prado AV, Skriabine S, et al. Neuroinvasion of SARS-CoV-2 in human and mouse brain. bioRxiv 2020:2020.06.25.169946.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7808299</ArticleId><ArticleId IdType="pubmed">33433624</ArticleId></ArticleIdList></Reference><Reference><Citation>Song E., Zhang C., Israelow B., Lu-Culligan A., Prado A.V., Skriabine S., et al. Neuroinvasion of SARS-CoV-2 in human and mouse brain. J Exp Med. 2021;218(3)</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7808299</ArticleId><ArticleId IdType="pubmed">33433624</ArticleId></ArticleIdList></Reference><Reference><Citation>Soriano J.B., Murthy S., Marshall J.C., Relan P., Diaz J.V. A clinical case definition of post-COVID-19 condition by a Delphi consensus. Lancet Infect Dis. 2022;22(4):e102&#x2013;e107.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8691845</ArticleId><ArticleId IdType="pubmed">34951953</ArticleId></ArticleIdList></Reference><Reference><Citation>Sumner P., Edden R.A., Bompas A., Evans C.J., Singh K.D. More GABA, less distraction: a neurochemical predictor of motor decision speed. Nat Neurosci. 2010;13(7):825&#x2013;827.</Citation><ArticleIdList><ArticleId IdType="pubmed">20512136</ArticleId></ArticleIdList></Reference><Reference><Citation>Tenforde M.W., Kim S.S., Lindsell C.J., Billig Rose E., Shapiro N.I., Files D.C., et al. Symptom Duration and Risk Factors for Delayed Return to Usual Health Among Outpatients with COVID-19 in a Multistate Health Care Systems Network - United States, March-June 2020. MMWR Morb Mortal Wkly Rep. 2020;69(30):993&#x2013;998.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7392393</ArticleId><ArticleId IdType="pubmed">32730238</ArticleId></ArticleIdList></Reference><Reference><Citation>Tokimura H., Di Lazzaro V., Tokimura Y., Oliviero A., Profice P., Insola A., et al. Short latency inhibition of human hand motor cortex by somatosensory input from the hand. J Physiol. 2000;523 Pt 2(2):503&#x2013;513.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2269813</ArticleId><ArticleId IdType="pubmed">10699092</ArticleId></ArticleIdList></Reference><Reference><Citation>Tremblay S., Rogasch N.C., Premoli I., Blumberger D.M., Casarotto S., Chen R., et al. Clinical utility and prospective of TMS-EEG. Clin Neurophysiol. 2019;130(5):802&#x2013;844.</Citation><ArticleIdList><ArticleId IdType="pubmed">30772238</ArticleId></ArticleIdList></Reference><Reference><Citation>Valls-Sol&#xe9; J., Pascual-Leone A., Wassermann E.M., Hallett M. Human motor evoked responses to paired transcranial magnetic stimuli. Electroencephalogr Clin Neurophysiol. 1992;85(6):355&#x2013;364.</Citation><ArticleIdList><ArticleId IdType="pubmed">1282453</ArticleId></ArticleIdList></Reference><Reference><Citation>Versace V., Sebastianelli L., Ferrazzoli D., Romanello R., Ortelli P., Saltuari L., et al. Intracortical GABAergic dysfunction in patients with fatigue and dysexecutive syndrome after COVID-19. Clin Neurophysiol. 2021;132(5):1138&#x2013;1143.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7954785</ArticleId><ArticleId IdType="pubmed">33774378</ArticleId></ArticleIdList></Reference><Reference><Citation>Vucic S., Cheah B.C., Kiernan M.C. Maladaptation of cortical circuits underlies fatigue and weakness in ALS. Amyotroph Lateral Scler. 2011;12(6):414&#x2013;420.</Citation><ArticleIdList><ArticleId IdType="pubmed">21830989</ArticleId></ArticleIdList></Reference><Reference><Citation>Yuki K., Fujiogi M., Koutsogiannaki S. COVID-19 pathophysiology: A review. Clin Immunol. 2020;215</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7169933</ArticleId><ArticleId IdType="pubmed">32325252</ArticleId></ArticleIdList></Reference><Reference><Citation>Ziemann U., Paulus W., Nitsche M.A., Pascual-Leone A., Byblow W.D., Berardelli A., et al. Consensus: Motor cortex plasticity protocols. Brain Stimul. 2008;1(3):164&#x2013;182.</Citation><ArticleIdList><ArticleId IdType="pubmed">20633383</ArticleId></ArticleIdList></Reference><Reference><Citation>Ziemann U., Reis J., Schwenkreis P., Rosanova M., Strafella A., Badawy R., et al. TMS and drugs revisited 2014. Clin Neurophysiol. 2015;126(10):1847&#x2013;1868.</Citation><ArticleIdList><ArticleId IdType="pubmed">25534482</ArticleId></ArticleIdList></Reference><Reference><Citation>Zimmermann T., Bartsch J.C., Beer A., Lomazzo E., Guggenhuber S., Lange M.D., et al. Impaired anandamide/palmitoylethanolamide signaling in hippocampal glutamatergic neurons alters synaptic plasticity, learning, and emotional responses. Neuropsychopharmacology. 2019;44(8):1377&#x2013;1388.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6784910</ArticleId><ArticleId IdType="pubmed">30532004</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>